Copper as an antimicrobial agent: Recent advances

I Salah, IP Parkin, E Allan - RSC advances, 2021 - pubs.rsc.org
From its uses in ancient civilisations, copper has an established history as an antimicrobial
agent. Extensive research has determined the efficacy and mechanism of copper's …

Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections

MS Linz, A Mattappallil, D Finkel, D Parker - Antibiotics, 2023 - mdpi.com
The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …

Activate: randomized clinical trial of BCG vaccination against infection in the elderly

EJ Giamarellos-Bourboulis, M Tsilika, S Moorlag… - Cell, 2020 - cell.com
BCG vaccination in children protects against heterologous infections and improves survival
independently of tuberculosis prevention. The phase III ACTIVATE trial assessed whether …

Current epidemiology, etiology, and burden of acute skin infections in the United States

KS Kaye, LA Petty, AF Shorr… - Clinical Infectious …, 2019 - academic.oup.com
The US burden of acute skin infections is substantial. While Staphylococcus aureus and
Streptococcus spp. are the most common causes, gram-negative bacteria and mixed …

Synthesis, characterization, and evaluation of antimicrobial activity of novel Chitosan/Tigecycline composite

AA Menazea, MM Eid, MK Ahmed - International journal of biological …, 2020 - Elsevier
With the increase of antibiotic resistance currently available at an alarming rate, new
improved films of Chitosan (CS) have been achieved with different levels of Tigecycline …

Staphylococcal skin and soft tissue infections

TJ Hatlen, LG Miller - Infectious Disease Clinics, 2021 - id.theclinics.com
Staphylococcus aureus, a ubiquitous pathogen, is the most common bacteria involved in
purulent acute bacterial skin and skin structure infections (ABSSSI) 1. Over the years …

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics

HN Leong, A Kurup, MY Tan, ALH Kwa… - Infection and drug …, 2018 - Taylor & Francis
Complicated skin and soft tissue infections (cSSTIs) represent the severe form of infectious
disease that involves deeper soft tissues. Involvement of methicillin-resistant …

A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin …

W O'Riordan, A McManus, J Teras… - Clinical Infectious …, 2018 - academic.oup.com
Background Delafloxacin is an intravenous (IV)/oral anionic fluoroquinolone with activity
against gram-positive (including methicillin-resistant Staphylococcus aureus [MRSA]), gram …

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre …

W O'Riordan, C Cardenas, E Shin, A Sirbu… - The Lancet Infectious …, 2019 - thelancet.com
Background Pathogen resistance and safety concerns limit oral antibiotic options for the
treatment of acute bacterial skin and skin structure infections (ABSSSI). We aimed to …

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind …

J Pullman, J Gardovskis, B Farley, E Sun… - Journal of …, 2017 - academic.oup.com
Background Delafloxacin is an investigational anionic fluoroquinolone in development for
oral or intravenous administration for the treatment of infections caused by Gram-positive …